YOLFTbeta
Oxford Nanopore Technologies Ltd

Oxford Nanopore Technologies Ltd

ONT · LSE · Healthcare / Biotechnology

199.00GBX-2.40 (-1.19%)

Price History

Full chart

Market Stats

Previous Close201.40
Open199.00
Day Range196.80 – 202.80
52-Week Range95.61 – 237.00
Volume1.10M
Market Cap2.18B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.12
Dividend Yield0.00%
Beta0.96
50-Day Avg155.12
200-Day Avg133.98

About

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA. The company offers MinION Mk 1D, a portable device for DNA and RNA sequencing; and GridION and GridION Q, a compact bench top device that delivers a version of hardware, software, and chemistry. It also provides PromethION products, such as PromethION 2, PromethION 24, and PromethION 48. The company has a collaboration with Cepheid to develop and commercialize automated infectious disease sequencing solutions. It operates in the region of Americas, Europe, the Middle East, Africa, India, and the Asia Pacific. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies plc in May 2008. Oxford Nanopore Technologies plc was incorporated in 2005 and is headquartered in Oxford, the United Kingdom.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Francis Albert Luc Van Parys
  • Employees1.31K
  • HeadquartersGosling Building, Oxford, United Kingdom, OX4 4DQ, UK
  • Websitehttps://nanoporetech.com

Leadership

  • Mr. Nicholas Patrick KeherCFO & Director · b. 1982
  • Dr. Gurdial Singh Sanghera Ph.D.Advisor · b. 1961
  • Mr. Francis Albert Luc Van ParysCEO & Executive Director · b. 1975
  • Prof. Hagan Bayley Ph.D.Co-Founder & Member of Technical Advisory Board
  • Dr. Lakmal JayasingheChief Scientific Officer
  • Mr. Andrew WatsonChief Information Officer
  • Mr. Jordan HermanSenior VP & General Counsel
  • Mr. John SchoellermanSenior Vice President of Corporate & Business Development

Financials

Income Statement

Currency: GBP2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue149.49K--746.00K4.53M13.79M32.52M52.06M113.86M133.66M198.60M169.67M183.19M223.90M
Growth (%)----+507.10%+204.42%+135.88%+60.08%+118.70%+17.39%+48.59%-14.57%+7.97%+22.22%
Cost of Revenue---564.00K3.88M7.06M16.51M26.44M66.98M60.47M74.79M79.19M77.80M92.60M
Gross Profit149.49K--182.00K645.00K6.73M16.02M25.62M46.88M73.19M123.81M90.48M105.39M131.30M
Gross Margin100.00%--24.40%14.24%48.79%49.25%49.21%41.17%54.76%62.34%53.33%57.53%58.64%
Operating Expense23.61M--44.40M65.60M72.61M78.19M106.51M119.94M237.73M222.29M259.09M257.73M286.60M
Operating Income-23.46M-28.94M-42.01M-44.22M-64.96M-65.89M-62.18M-80.89M-73.06M-164.53M-98.48M-168.61M-152.33M-155.30M
Operating Margin-15694.40%---5927.08%-1434.29%-477.89%-191.19%-155.38%-64.17%-123.10%-49.59%-99.38%-83.16%-69.36%
EBITDA-22.57M-28.00M-40.97M-43.22M-63.62M-64.09M-55.25M-65.03M-55.07M-140.34M-49.67M-105.71M-93.09M-87.30M
EBITDA Margin-15097.05%---5792.90%-1404.64%-464.88%-169.88%-124.90%-48.37%-105.00%-25.01%-62.30%-50.82%-38.99%
Net Income-19.16M-24.21M-36.97M-38.51M-59.10M-56.54M-53.12M-72.22M-61.24M-167.61M-91.03M-154.51M-146.19M-145.20M
Net Income Margin-12816.49%---5162.33%-1304.95%-410.07%-163.34%-138.71%-53.79%-125.40%-45.83%-91.06%-79.80%-64.85%
R&D17.57M21.04M28.36M26.66M38.11M34.98M37.10M40.46M48.55M75.98M64.84M103.84M98.92M97.70M
R&D as % of Total Revenue11752.33%--3573.19%841.47%253.71%114.09%77.71%42.64%56.84%32.65%61.20%54.00%43.64%
Interest Expense-----0423.00K614.00K747.00K908.00K1.63M2.21M3.56M2.80M
Interest Expense % of Total Revenue-----0.00%1.30%1.18%0.66%0.68%0.82%1.30%1.95%1.25%

Balance Sheet

Currency: GBP2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets51.95M68.87M70.30M108.77M158.94M119.31M175.19M164.74M281.21M841.87M823.89M777.06M742.05M622.50M
Total Liabilities2.01M3.10M4.28M8.29M13.71M25.72M32.30M55.21M95.28M137.89M130.33M133.21M155.71M159.20M
Total Equity49.94M65.57M65.61M99.71M144.24M93.58M142.89M109.53M185.93M703.98M693.56M643.85M586.34M463.30M
Cash21.92M28.12M24.86M52.60M64.07M57.80M35.32M13.09M80.86M487.84M356.78M220.54M199.52M181.10M
Total Debt-----9.50M9.50M19.08M23.63M24.80M34.10M41.66M45.96M41.50M
Net Debt-21.92M-28.12M-24.86M-52.60M-64.07M-48.30M-25.82M5.99M-57.23M-463.04M-322.68M-178.88M-153.55M-139.60M

Cash Flow

Currency: GBP2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-21.27M-23.27M-33.88M-33.14M-51.21M-66.34M-55.51M-48.68M-63.81M-53.83M-49.39M-137.30M-109.89M-62.80M
Investing Cash Flow4.80M-10.20M-4.33M-9.51M-2.50M-19.58M-65.42M28.52M-26.94M-161.99M-65.79M-61.79M15.03M48.50M
Financing Cash Flow31.66M39.69M34.93M70.37M65.15M79.71M98.40M-1.99M158.58M622.90M-13.71M64.73M73.58M-2.10M
Capital Expenditure869.84K736.00K1.64M962.00K3.03M19.72M17.80M30.29M26.47M30.82M42.23M27.29M13.94M3.50M
Free Cash Flow-22.14M-24.01M-35.51M-34.10M-54.24M-86.07M-73.31M-78.97M-90.28M-84.64M-91.62M-164.59M-123.83M-66.30M
FCF to OCF104.09%103.16%104.83%102.90%105.92%129.73%132.07%162.23%141.49%157.25%185.52%119.88%112.69%105.57%

Earnings

Report DateSep 30, 2021Mar 22, 2022Sep 13, 2022Mar 21, 2023Jun 10, 2025Sep 2, 2025Mar 3, 2027
EPS Estimate0.00-0.09-0.08-0.06-0.10-0.08-
EPS Actual-0.03-0.19-0.04-0.07-0.08-0.07-
Surprise--111.11%50.00%-16.67%20.00%6.25%-
Timing----After-hoursAfter-hoursPre-market

Key Statistics & Ratios

Market Cap2.18B
Enterprise Value1.57B
Trailing P/E0.00
Forward P/E0.00
Price / Sales9.29
Price / Book4.05
EPS-0.12
Book Value0.435
Revenue (TTM)235.00M
Gross Profit (TTM)147.60M
EBITDA-92.40M
Profit Margin-51.66%
Operating Margin-43.45%
Return on Equity-25.63%
Return on Assets-10.94%
Shares Outstanding978.45M
Shares Float459.27M
Beta0.96
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%